Stockreport

Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell [Yahoo! Finance]

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced the appointment of Kimberly Blackwell, MD, to its Board of [Read more]